Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amylin Pharmaceuticals Inc (AMLN) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Amylin Pharmaceuticals Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. The reporting company's CIK number is 881464.
Total stock buying since 2005: $166,931,228.
Total stock sales since 2005: $345,918,013.
Total stock option exercises since 2005: $11,112,250.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-07 | 0 | $0 | 0 | $0 | 56,300 | $672,785 |
| 2012-05 | 0 | $0 | 0 | $0 | 18,000 | $167,040 |
| 2012-03 | 0 | $0 | 20,616 | $405,007 | 5,000 | $45,100 |
| 2012-02 | 0 | $0 | 63,142 | $1,067,438 | 0 | $0 |
| 2012-01 | 0 | $0 | 1,832 | $21,232 | 5,993 | $0 |
| 2011-10 | 0 | $0 | 15,000 | $131,220 | 62,500 | $358,125 |
| 2011-05 | 0 | $0 | 0 | $0 | 3,000 | $33,090 |
| 2011-03 | 0 | $0 | 13,750 | $206,525 | 13,750 | $128,246 |
| 2011-02 | 0 | $0 | 12,500 | $202,035 | 12,500 | $139,060 |
| 2011-01 | 0 | $0 | 3,170 | $47,509 | 2,500 | $27,812 |
| 2010-11 | 0 | $0 | 1,314 | $17,633 | 25,000 | $278,125 |
| 2010-05 | 0 | $0 | 0 | $0 | 10,000 | $102,500 |
| 2010-04 | 0 | $0 | 0 | $0 | 638 | $8,453 |
| 2010-03 | 0 | $0 | 0 | $0 | 5,000 | $48,125 |
| 2010-02 | 0 | $0 | 0 | $0 | 72,606 | $1,036,886 |
| 2009-09 | 0 | $0 | 3,853,880 | $54,287,588 | 0 | $0 |
| 2009-02 | 0 | $0 | 0 | $0 | 16,344 | $12,764 |
| 2008-08 | 0 | $0 | 10,309,375 | $217,453,877 | 100 | $1,654 |
| 2008-06 | 261,207 | $7,815,313 | 0 | $0 | 0 | $0 |
| 2008-05 | 416,619 | $11,623,670 | 40,000 | $1,280,090 | 0 | $0 |
| 2008-04 | 4,502,240 | $131,997,310 | 60,000 | $1,925,620 | 0 | $0 |
| 2008-03 | 459,881 | $12,639,294 | 0 | $0 | 5,608 | $13,711 |
| 2008-02 | 75,000 | $2,014,300 | 8,308 | $254,047 | 76,724 | $326,259 |
| 2008-01 | 0 | $0 | 40,100 | $1,408,331 | 14,700 | $105,497 |
| 2007-12 | 0 | $0 | 41,100 | $1,551,648 | 22,700 | $148,395 |
| 2007-11 | 0 | $0 | 44,600 | $1,838,190 | 96,645 | $443,628 |
| 2007-10 | 0 | $0 | 51,800 | $2,510,251 | 20,700 | $214,490 |
| 2007-09 | 0 | $0 | 56,100 | $2,744,786 | 30,150 | $303,238 |
| 2007-08 | 0 | $0 | 109,914 | $5,427,298 | 73,700 | $858,126 |
| 2007-07 | 0 | $0 | 50,892 | $2,188,094 | 163,200 | $582,607 |
| 2007-06 | 0 | $0 | 53,892 | $2,406,633 | 39,098 | $486,521 |
| 2007-05 | 0 | $0 | 84,618 | $3,679,999 | 49,200 | $571,623 |
| 2007-04 | 0 | $0 | 54,738 | $2,196,776 | 20,700 | $118,979 |
| 2007-03 | 0 | $0 | 41,892 | $1,573,307 | 50,969 | $482,549 |
| 2007-02 | 0 | $0 | 27,892 | $1,107,171 | 16,700 | $140,907 |
| 2007-01 | 0 | $0 | 25,192 | $990,690 | 133,479 | $409,497 |
| 2006-12 | 0 | $0 | 32,692 | $1,254,682 | 29,673 | $354,844 |
| 2006-11 | 0 | $0 | 68,192 | $2,963,196 | 17,500 | $142,856 |
| 2006-10 | 0 | $0 | 62,038 | $2,752,057 | 17,500 | $163,626 |
| 2006-09 | 0 | $0 | 62,525 | $2,849,235 | 18,500 | $173,175 |
| 2006-08 | 0 | $0 | 79,038 | $3,498,594 | 21,593 | $175,972 |
| 2006-07 | 0 | $0 | 61,038 | $2,974,139 | 8,500 | $91,454 |
| 2006-06 | 0 | $0 | 30,846 | $1,417,078 | 18,869 | $286,120 |
| 2006-05 | 0 | $0 | 66,384 | $2,842,093 | 18,000 | $76,945 |
| 2006-04 | 0 | $0 | 59,692 | $2,758,785 | 23,000 | $121,569 |
| 2006-03 | 0 | $0 | 58,192 | $2,587,719 | 19,500 | $81,126 |
| 2006-02 | 0 | $0 | 97,846 | $3,951,179 | 54,154 | $72,276 |
| 2006-01 | 0 | $0 | 65,121 | $2,735,444 | 100,555 | $1,086,930 |
| 2005-12 | 0 | $0 | 39,940 | $1,543,914 | 3,500 | $19,565 |
| 2005-11 | 0 | $0 | 39,692 | $1,420,951 | 0 | $0 |
| 2005-10 | 0 | $0 | 34,692 | $1,215,665 | 0 | $0 |
| 2005-09 | 0 | $0 | 34,692 | $1,112,681 | 0 | $0 |
| 2005-08 | 0 | $0 | 13,538 | $317,177 | 0 | $0 |
| 2005-07 | 0 | $0 | 9,192 | $196,042 | 0 | $0 |
| 2005-06 | 0 | $0 | 31,692 | $604,387 | 0 | $0 |
| 2005-05 | 50,000 | $841,341 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-08-01 | Baron Alain D (Sr VP Research) | Option Ex | 3,000 | 5.73 | 17,190 |
| 2006-08-01 | Greene Howard E Jr (Director) | Sale | 10,000 | 47.74 | 477,360 |
| 2006-07-31 | Greene Howard E Jr (Director) | Sale | 3,846 | 48.23 | 185,488 |
| 2006-07-25 | Cook Joseph C Jr (Director) | Sale | 10,000 | 48.65 | 486,460 |
| 2006-07-17 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,000 | 48.38 | 96,764 |
| 2006-07-17 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,000 | 11.56 | 23,124 |
| 2006-07-17 | Greene Howard E Jr (Director) | Sale | 3,846 | 48.02 | 184,696 |
| 2006-07-14 | Cook Joseph C Jr (Director) | Sale | 10,000 | 48.62 | 486,230 |
| 2006-07-10 | Bradbury Daniel (Chief Operating Officer) | Sale | 3,500 | 49.88 | 174,587 |
| 2006-07-10 | Wilson James N (Director) | Sale | 7,500 | 50.00 | 375,007 |
| 2006-07-03 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 48.02 | 96,040 |
| 2006-07-03 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-07-03 | Eberhard Craig A (VP Sales) | Sale | 1,500 | 48.01 | 72,016 |
| 2006-07-03 | Eberhard Craig A (VP Sales) | Option Ex | 1,500 | 18.85 | 28,275 |
| 2006-07-03 | Baron Alain D (Sr VP Research) | Sale | 3,000 | 48.86 | 146,580 |
| 2006-07-03 | Baron Alain D (Sr VP Research) | Option Ex | 3,000 | 9.62 | 28,875 |
| 2006-07-03 | Greene Howard E Jr (Director) | Sale | 13,846 | 48.41 | 670,271 |
| 2006-06-29 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-06-29 | Cook Joseph C Jr (Director) | Sale | 10,000 | 47.02 | 470,180 |
| 2006-06-12 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-06-09 | Graham Ginger L (President and Chief Executive) | Option Ex | 10,869 | 19.77 | 214,880 |
| 2006-06-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 3,000 | 44.92 | 134,775 |
| 2006-06-05 | Greene Howard E Jr (Director) | Sale | 3,846 | 46.74 | 179,773 |
| 2006-06-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 45.57 | 91,140 |
| 2006-06-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-06-01 | Eberhard Craig A (VP Sales) | Sale | 2,000 | 46.12 | 92,230 |
| 2006-06-01 | Eberhard Craig A (VP Sales) | Option Ex | 2,000 | 18.85 | 37,700 |
| 2006-06-01 | Greene Howard E Jr (Director) | Sale | 10,000 | 44.90 | 448,980 |
| 2006-05-30 | Cook Joseph C Jr (Director) | Sale | 10,000 | 44.40 | 444,030 |
| 2006-05-26 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 45.00 | 45,000 |
| 2006-05-26 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 7.19 | 7,187 |
| 2006-05-22 | Greene Howard E Jr (Director) | Sale | 7,692 | 40.03 | 307,932 |
| 2006-05-15 | Foletta Mark G (VP Finance & CFO) | Sale | 2,000 | 42.75 | 85,500 |
| 2006-05-15 | Foletta Mark G (VP Finance & CFO) | Option Ex | 2,000 | 11.11 | 22,224 |
| 2006-05-15 | Cook Joseph C Jr (Director) | Sale | 10,000 | 42.40 | 423,970 |
| 2006-05-08 | Greene Howard E Jr (Director) | Sale | 3,846 | 43.54 | 167,466 |
| 2006-05-05 | Bradbury Daniel (Chief Operating Officer) | Sale | 3,000 | 43.30 | 129,899 |
| 2006-05-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 43.00 | 86,000 |
| 2006-05-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-05-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 10,000 | 43.44 | 434,400 |
| 2006-05-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 10,000 | .31 | 3,130 |
| 2006-05-01 | Eberhard Craig A (VP Sales) | Sale | 1,000 | 43.01 | 43,010 |
| 2006-05-01 | Eberhard Craig A (VP Sales) | Option Ex | 1,000 | 18.85 | 18,850 |
| 2006-05-01 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.44 | 86,880 |
| 2006-05-01 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 7.19 | 14,374 |
| 2006-05-01 | Greene Howard E Jr (Director) | Sale | 10,000 | 43.40 | 434,040 |
| 2006-04-28 | Cook Joseph C Jr (Director) | Sale | 10,000 | 43.90 | 439,000 |
| 2006-04-24 | Greene Howard E Jr (Director) | Sale | 3,846 | 46.87 | 180,277 |
| 2006-04-17 | Foletta Mark G (VP Finance & CFO) | Sale | 2,000 | 48.84 | 97,680 |
| 2006-04-17 | Foletta Mark G (VP Finance & CFO) | Option Ex | 2,000 | 9.62 | 19,250 |
| 2006-04-11 | Cook Joseph C Jr (Director) | Sale | 10,000 | 44.49 | 444,940 |
| 2006-04-10 | Greene Howard E Jr (Director) | Sale | 3,846 | 44.61 | 171,558 |
| 2006-04-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 3,000 | 46.10 | 138,300 |
| 2006-04-06 | Baron Alain D (Sr VP Research) | Option Ex | 4,000 | 7.19 | 28,748 |
| 2006-04-03 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 46.88 | 93,770 |
| 2006-04-03 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-04-03 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 10,000 | 48.51 | 485,100 |
| 2006-04-03 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 10,000 | .31 | 3,130 |
| 2006-04-03 | Eberhard Craig A (VP Sales) | Sale | 2,000 | 46.88 | 93,770 |
| 2006-04-03 | Eberhard Craig A (VP Sales) | Option Ex | 2,000 | 18.85 | 37,700 |
| 2006-04-03 | Baron Alain D (Sr VP Research) | Sale | 3,000 | 48.51 | 145,530 |
| 2006-04-03 | Baron Alain D (Sr VP Research) | Option Ex | 3,000 | 7.19 | 21,561 |
| 2006-04-03 | Greene Howard E Jr (Director) | Sale | 10,000 | 46.89 | 468,860 |
| 2006-03-30 | Cook Joseph C Jr (Director) | Sale | 10,000 | 47.78 | 477,760 |
| 2006-03-27 | Greene Howard E Jr (Director) | Sale | 3,846 | 44.92 | 172,746 |
| 2006-03-16 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 45.00 | 45,000 |
| 2006-03-16 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 7.19 | 7,187 |
| 2006-03-16 | Cook Joseph C Jr (Director) | Sale | 10,000 | 45.61 | 456,070 |
| 2006-03-15 | Foletta Mark G (VP Finance & CFO) | Sale | 2,500 | 43.91 | 109,774 |
| 2006-03-15 | Foletta Mark G (VP Finance & CFO) | Option Ex | 2,500 | 8.33 | 20,815 |
| 2006-03-13 | Greene Howard E Jr (Director) | Sale | 6,346 | 42.67 | 270,802 |
| 2006-03-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 4,000 | 42.50 | 170,000 |
| 2006-03-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 3,000 | 43.00 | 129,000 |
| 2006-03-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 3,000 | 5.59 | 16,770 |
| 2006-03-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 10,000 | 43.35 | 433,500 |
| 2006-03-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 10,000 | .31 | 3,130 |
| 2006-03-01 | Eberhard Craig A (VP Sales) | Sale | 1,000 | 43.00 | 43,000 |
| 2006-03-01 | Eberhard Craig A (VP Sales) | Option Ex | 1,000 | 18.85 | 18,850 |
| 2006-03-01 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.35 | 86,700 |
| 2006-03-01 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 7.19 | 14,374 |
| 2006-03-01 | Greene Howard E Jr (Director) | Sale | 2,500 | 43.35 | 108,367 |
| 2006-02-28 | Cook Joseph C Jr (Director) | Sale | 10,000 | 43.52 | 435,190 |
| 2006-02-27 | Greene Howard E Jr (Director) | Sale | 3,846 | 43.49 | 167,251 |
| 2006-02-23 | Bradbury Daniel (Chief Operating Officer) | Sale | 12,552 | 41.00 | 514,632 |
| 2006-02-23 | Bradbury Daniel (Chief Operating Officer) | Option Ex | 12,552 | .78 | 9,803 |
| 2006-02-21 | Bradbury Daniel (Chief Operating Officer) | Sale | 12,551 | 39.65 | 497,647 |
| 2006-02-21 | Bradbury Daniel (Chief Operating Officer) | Option Ex | 12,551 | .78 | 9,802 |
| 2006-02-16 | Bradbury Daniel (Chief Operating Officer) | Sale | 12,551 | 38.25 | 480,075 |
| 2006-02-16 | Bradbury Daniel (Chief Operating Officer) | Option Ex | 12,551 | .78 | 9,802 |
| 2006-02-16 | Greene Howard E Jr (Director) | Sale | 2,500 | 38.80 | 97,000 |
| 2006-02-15 | Foletta Mark G (VP Finance & CFO) | Sale | 1,500 | 37.70 | 56,550 |
| 2006-02-15 | Foletta Mark G (VP Finance & CFO) | Option Ex | 1,500 | 5.73 | 8,595 |
| 2006-02-14 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.21 | 372,100 |
| 2006-02-13 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.08 | 142,613 |
| 2006-02-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 2,000 | 38.00 | 76,000 |
| 2006-02-01 | Rowland Lloyd A (VP Legal & General C) | Sale | 3,000 | 41.71 | 125,121 |
| 2006-02-01 | Rowland Lloyd A (VP Legal & General C) | Option Ex | 3,000 | 5.59 | 16,770 |
| 2006-02-01 | Kolterman Orville G (Sr VP Clinical and R) | Sale | 10,000 | 42.00 | 420,000 |
| 2006-02-01 | Kolterman Orville G (Sr VP Clinical and R) | Option Ex | 10,000 | .31 | 3,130 |
| 2006-02-01 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 42.00 | 84,000 |
| 2006-02-01 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 7.19 | 14,374 |
| 2006-02-01 | Elwood Dwayne M (Sr VP Marketing) | Sale | 11,500 | 42.00 | 483,000 |
| 2006-01-31 | Greene Howard E Jr (Director) | Sale | 2,500 | 42.33 | 105,827 |
| 2006-01-30 | Greene Howard E Jr (Director) | Sale | 3,846 | 43.69 | 168,031 |
| 2006-01-27 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 45.00 | 45,000 |
| 2006-01-27 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 7.19 | 7,187 |
| 2006-01-27 | Wilson James N (Director) | Sale | 8,500 | 45.08 | 383,137 |
| 2006-01-25 | Cook Joseph C Jr (Director) | Sale | 10,000 | 42.60 | 426,000 |
| 2006-01-20 | Greene Howard E Jr (Director) | Sale | 2,500 | 44.34 | 110,845 |
| 2006-01-17 | Rowland Lloyd A (VP Legal & General C) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-01-17 | Foletta Mark G (VP Finance & CFO) | Sale | 2,000 | 43.00 | 86,000 |
| 2006-01-17 | Foletta Mark G (VP Finance & CFO) | Option Ex | 2,000 | 5.73 | 11,460 |
| 2006-01-17 | Greene Howard E Jr (Director) | Sale | 3,846 | 43.06 | 165,608 |
| 2006-01-09 | Bradbury Daniel (Chief Operating Officer) | Sale | 2,000 | 43.00 | 86,000 |
| 2006-01-09 | Cook Joseph C Jr (Director) | Option Ex | 60,000 | 12.31 | 738,780 |
| 2006-01-05 | Bradbury Daniel (Chief Operating Officer) | Option Ex | 12,972 | 4.94 | 64,055 |
| 2006-01-05 | Graham Ginger L (President and Chief) | Option Ex | 10,000 | 12.25 | 122,500 |
| 2006-01-05 | Cook Joseph C Jr (Director) | Sale | 10,000 | 40.21 | 402,100 |
| 2006-01-05 | Greene Howard E Jr (Director) | Sale | 2,500 | 40.24 | 100,605 |
| 2006-01-03 | Rowland Lloyd A (VP Legal & General C) | Sale | 2,000 | 40.00 | 80,000 |
| 2006-01-03 | Rowland Lloyd A (VP Legal & General C) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-01-03 | Kolterman Orville G (Sr VP Clinical and R) | Sale | 8,583 | 40.01 | 343,405 |
| 2006-01-03 | Kolterman Orville G (Sr VP Clinical and R) | Option Ex | 8,583 | 12.38 | 106,214 |
| 2006-01-03 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 40.00 | 80,000 |
| 2006-01-03 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 7.19 | 14,374 |
| 2006-01-03 | Greene Howard E Jr (Director) | Sale | 3,846 | 39.75 | 152,886 |
| 2005-12-30 | Rowland Lloyd A (VP Legal & General C) | Sale | 3,500 | 39.75 | 139,125 |
| 2005-12-30 | Rowland Lloyd A (VP Legal & General C) | Option Ex | 3,500 | 5.59 | 19,565 |
| 2005-12-20 | Wilson James N (Director) | Sale | 8,000 | 40.00 | 320,000 |
| 2005-12-19 | Data Joann L (Sr VP Corporate Assi) | Sale | 8,748 | 38.68 | 338,372 |
| 2005-12-19 | Greene Howard E Jr (Director) | Sale | 3,846 | 39.03 | 150,113 |
| 2005-12-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 2,000 | 37.20 | 74,402 |
| 2005-12-06 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.72 | 377,170 |
| 2005-12-05 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.63 | 144,732 |
| 2005-11-22 | Cook Joseph C Jr (Director) | Sale | 10,000 | 38.40 | 383,960 |
| 2005-11-21 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.32 | 143,528 |
| 2005-11-08 | Data Joann L (Sr VP Corporate Assi) | Sale | 20,000 | 34.52 | 690,380 |
| 2005-11-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 2,000 | 34.75 | 69,500 |
| 2005-11-07 | Greene Howard E Jr (Director) | Sale | 3,846 | 34.73 | 133,583 |
| 2005-10-28 | Cook Joseph C Jr (Director) | Sale | 12,500 | 33.83 | 422,850 |
| 2005-10-24 | Greene Howard E Jr (Director) | Sale | 3,846 | 36.10 | 138,836 |
| 2005-10-14 | Cook Joseph C Jr (Director) | Sale | 12,500 | 36.26 | 453,212 |
| 2005-10-10 | Greene Howard E Jr (Director) | Sale | 3,846 | 34.13 | 131,267 |
| 2005-10-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 2,000 | 34.75 | 69,500 |
| 2005-09-29 | Cook Joseph C Jr (Director) | Sale | 12,500 | 34.48 | 431,037 |
| 2005-09-26 | Greene Howard E Jr (Director) | Sale | 3,846 | 31.59 | 121,483 |
| 2005-09-16 | Cook Joseph C Jr (Director) | Sale | 12,500 | 30.11 | 376,312 |
| 2005-09-12 | Greene Howard E Jr (Director) | Sale | 3,846 | 31.29 | 120,349 |
| 2005-09-08 | Bradbury Daniel (Chief Operating Officer) | Sale | 2,000 | 31.75 | 63,500 |
| 2005-08-29 | Greene Howard E Jr (Director) | Sale | 3,846 | 31.87 | 122,587 |
| 2005-08-15 | Greene Howard E Jr (Director) | Sale | 3,846 | 20.19 | 77,650 |
| 2005-08-05 | Bradbury Daniel (Chief Operating Officer) | Sale | 2,000 | 20.01 | 40,020 |
| 2005-08-01 | Greene Howard E Jr (Director) | Sale | 3,846 | 20.00 | 76,920 |
| 2005-07-18 | Greene Howard E Jr (Director) | Sale | 3,846 | 21.85 | 84,027 |
| 2005-07-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 1,500 | 20.50 | 30,750 |
| 2005-07-05 | Greene Howard E Jr (Director) | Sale | 3,846 | 21.13 | 81,265 |
| 2005-06-20 | Greene Howard E Jr (Director) | Sale | 3,846 | 20.45 | 78,650 |
| 2005-06-17 | Greene Howard E Jr (Director) | Sale | 3,846 | 20.40 | 78,473 |
| 2005-06-15 | Cook Joseph C Jr (Director) | Sale | 24,000 | 18.64 | 447,264 |
| 2005-05-10 | Eberhard Craig A (VP Sales) | Buy | 11,500 | 17.35 | 199,525 |
| 2005-05-09 | Elwood Dwayne M (Sr VP Marketing) | Buy | 3,500 | 16.75 | 58,607 |
| 2005-05-06 | Gregg Terrance H (Director) | Buy | 3,000 | 16.37 | 49,110 |
| 2005-05-06 | Graham Ginger L (President and Chief) | Buy | 12,000 | 16.65 | 199,799 |
| 2005-05-06 | Bryson Vaughn D (Director) | Buy | 20,000 | 16.71 | 334,300 |
Insider trading activities including stock purchases, stock sales, and option exercises of AMLN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amylin Pharmaceuticals Inc (symbol AMLN, CIK number 881464) see the Securities and Exchange Commission (SEC) website.